http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2959132-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a9e6421e9257148abad101e1ce6c162 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G09B19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-343 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-343 |
| filingDate | 2010-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0de77a9d9067b29d36b161c61400e53 |
| publicationDate | 2011-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | FR-2959132-A1 |
| titleOfInvention | METHODS FOR RISK EVALUATION AND REDUCTION |
| abstract | This invention relates to methods of reducing the risk of use of dronedarone in certain patient populations. |
| priorityDate | 2010-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 60.